Delivery Order SPE2DB22D1106-SPE2DB23FEYA0
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $18,774.53, is for the delivery of the drug Sprycel 100 mg tablets. The award has a completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $10,774.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Sprycel 140 mg tablets, a specialty pharmaceutical product, with a completion date of January 16, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sprycel 140 mg tablets. The award, valued at $5,384.28, is a firm fixed-price delivery order with a completion date of December 16, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $99,951.13 and covers the delivery of pharmaceutical products, including the drug Sprycel 100mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,642.54 delivery order contract is for the supply of Sprycel 100 MG Tablet 30S, a pharmaceutical product, under a firm fixed price arrangement. The contract has an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical program. The $17,150.55 firm fixed price delivery order is for the supply of the pharmaceutical product Sprycel 100 mg tablet, with a period of performance through April 4, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is associated with a larger indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,399.40, is for the delivery of the medication Sprycel 70 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award, valued at $16,706.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Sprycel 100 mg tablet, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price valued at $10,645.34, for the supply of Sprycel 100 mg tablets. The ultimate completion date for this award is March 26, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEYA0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,506.59 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg tablet, with a completion date of September 7, 2023. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and other government medical institutions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 9/6/23 |